Global Active Pharmaceutical Ingredients (API) CDMO Supply, Demand and Key Producers, 2023-2029
The global Active Pharmaceutical Ingredients (API) CDMO market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
This report studies the global Active Pharmaceutical Ingredients (API) CDMO demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Active Pharmaceutical Ingredients (API) CDMO, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Active Pharmaceutical Ingredients (API) CDMO that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Active Pharmaceutical Ingredients (API) CDMO total market, 2018-2029, (USD Million)
Global Active Pharmaceutical Ingredients (API) CDMO total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Active Pharmaceutical Ingredients (API) CDMO total market, key domestic companies and share, (USD Million)
Global Active Pharmaceutical Ingredients (API) CDMO revenue by player and market share 2018-2023, (USD Million)
Global Active Pharmaceutical Ingredients (API) CDMO total market by Type, CAGR, 2018-2029, (USD Million)
Global Active Pharmaceutical Ingredients (API) CDMO total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Active Pharmaceutical Ingredients (API) CDMO market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Recipharm, Cambrex Corporation, Patheon (Thermo Fisher Scientific), CordenPharma, Lonza, Siegfried, Catalent, Boehringer Ingelheim and Piramal Group, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Active Pharmaceutical Ingredients (API) CDMO market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Active Pharmaceutical Ingredients (API) CDMO Market, By Region:
1. How big is the global Active Pharmaceutical Ingredients (API) CDMO market?
2. What is the demand of the global Active Pharmaceutical Ingredients (API) CDMO market?
3. What is the year over year growth of the global Active Pharmaceutical Ingredients (API) CDMO market?
4. What is the total value of the global Active Pharmaceutical Ingredients (API) CDMO market?
5. Who are the major players in the global Active Pharmaceutical Ingredients (API) CDMO market?
6. What are the growth factors driving the market demand?
This report studies the global Active Pharmaceutical Ingredients (API) CDMO demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Active Pharmaceutical Ingredients (API) CDMO, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Active Pharmaceutical Ingredients (API) CDMO that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Active Pharmaceutical Ingredients (API) CDMO total market, 2018-2029, (USD Million)
Global Active Pharmaceutical Ingredients (API) CDMO total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Active Pharmaceutical Ingredients (API) CDMO total market, key domestic companies and share, (USD Million)
Global Active Pharmaceutical Ingredients (API) CDMO revenue by player and market share 2018-2023, (USD Million)
Global Active Pharmaceutical Ingredients (API) CDMO total market by Type, CAGR, 2018-2029, (USD Million)
Global Active Pharmaceutical Ingredients (API) CDMO total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Active Pharmaceutical Ingredients (API) CDMO market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Recipharm, Cambrex Corporation, Patheon (Thermo Fisher Scientific), CordenPharma, Lonza, Siegfried, Catalent, Boehringer Ingelheim and Piramal Group, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Active Pharmaceutical Ingredients (API) CDMO market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Active Pharmaceutical Ingredients (API) CDMO Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Macromolecular API
- Small Molecule API
- Clinical
- Commercial
- Others
- Recipharm
- Cambrex Corporation
- Patheon (Thermo Fisher Scientific)
- CordenPharma
- Lonza
- Siegfried
- Catalent
- Boehringer Ingelheim
- Piramal Group
- AbbVie
- SGS Quay Pharmaceuticals
- Aenova Group
- Curia
- Sterling Pharma Solutions
- Eurofins CDMO
1. How big is the global Active Pharmaceutical Ingredients (API) CDMO market?
2. What is the demand of the global Active Pharmaceutical Ingredients (API) CDMO market?
3. What is the year over year growth of the global Active Pharmaceutical Ingredients (API) CDMO market?
4. What is the total value of the global Active Pharmaceutical Ingredients (API) CDMO market?
5. Who are the major players in the global Active Pharmaceutical Ingredients (API) CDMO market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Active Pharmaceutical Ingredients (API) CDMO Introduction
1.2 World Active Pharmaceutical Ingredients (API) CDMO Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Active Pharmaceutical Ingredients (API) CDMO Total Market by Region (by Headquarter Location)
1.3.1 World Active Pharmaceutical Ingredients (API) CDMO Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Active Pharmaceutical Ingredients (API) CDMO Market Size (2018-2029)
1.3.3 China Active Pharmaceutical Ingredients (API) CDMO Market Size (2018-2029)
1.3.4 Europe Active Pharmaceutical Ingredients (API) CDMO Market Size (2018-2029)
1.3.5 Japan Active Pharmaceutical Ingredients (API) CDMO Market Size (2018-2029)
1.3.6 South Korea Active Pharmaceutical Ingredients (API) CDMO Market Size (2018-2029)
1.3.7 ASEAN Active Pharmaceutical Ingredients (API) CDMO Market Size (2018-2029)
1.3.8 India Active Pharmaceutical Ingredients (API) CDMO Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Active Pharmaceutical Ingredients (API) CDMO Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Active Pharmaceutical Ingredients (API) CDMO Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Active Pharmaceutical Ingredients (API) CDMO Consumption Value (2018-2029)
2.2 World Active Pharmaceutical Ingredients (API) CDMO Consumption Value by Region
2.2.1 World Active Pharmaceutical Ingredients (API) CDMO Consumption Value by Region (2018-2023)
2.2.2 World Active Pharmaceutical Ingredients (API) CDMO Consumption Value Forecast by Region (2024-2029)
2.3 United States Active Pharmaceutical Ingredients (API) CDMO Consumption Value (2018-2029)
2.4 China Active Pharmaceutical Ingredients (API) CDMO Consumption Value (2018-2029)
2.5 Europe Active Pharmaceutical Ingredients (API) CDMO Consumption Value (2018-2029)
2.6 Japan Active Pharmaceutical Ingredients (API) CDMO Consumption Value (2018-2029)
2.7 South Korea Active Pharmaceutical Ingredients (API) CDMO Consumption Value (2018-2029)
2.8 ASEAN Active Pharmaceutical Ingredients (API) CDMO Consumption Value (2018-2029)
2.9 India Active Pharmaceutical Ingredients (API) CDMO Consumption Value (2018-2029)
3 WORLD ACTIVE PHARMACEUTICAL INGREDIENTS (API) CDMO COMPANIES COMPETITIVE ANALYSIS
3.1 World Active Pharmaceutical Ingredients (API) CDMO Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Active Pharmaceutical Ingredients (API) CDMO Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Active Pharmaceutical Ingredients (API) CDMO in 2022
3.2.3 Global Concentration Ratios (CR8) for Active Pharmaceutical Ingredients (API) CDMO in 2022
3.3 Active Pharmaceutical Ingredients (API) CDMO Company Evaluation Quadrant
3.4 Active Pharmaceutical Ingredients (API) CDMO Market: Overall Company Footprint Analysis
3.4.1 Active Pharmaceutical Ingredients (API) CDMO Market: Region Footprint
3.4.2 Active Pharmaceutical Ingredients (API) CDMO Market: Company Product Type Footprint
3.4.3 Active Pharmaceutical Ingredients (API) CDMO Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Active Pharmaceutical Ingredients (API) CDMO Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Active Pharmaceutical Ingredients (API) CDMO Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Active Pharmaceutical Ingredients (API) CDMO Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Active Pharmaceutical Ingredients (API) CDMO Consumption Value Comparison
4.2.1 United States VS China: Active Pharmaceutical Ingredients (API) CDMO Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Active Pharmaceutical Ingredients (API) CDMO Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Active Pharmaceutical Ingredients (API) CDMO Companies and Market Share, 2018-2023
4.3.1 United States Based Active Pharmaceutical Ingredients (API) CDMO Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Active Pharmaceutical Ingredients (API) CDMO Revenue, (2018-2023)
4.4 China Based Companies Active Pharmaceutical Ingredients (API) CDMO Revenue and Market Share, 2018-2023
4.4.1 China Based Active Pharmaceutical Ingredients (API) CDMO Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Active Pharmaceutical Ingredients (API) CDMO Revenue, (2018-2023)
4.5 Rest of World Based Active Pharmaceutical Ingredients (API) CDMO Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Active Pharmaceutical Ingredients (API) CDMO Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Active Pharmaceutical Ingredients (API) CDMO Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Active Pharmaceutical Ingredients (API) CDMO Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Macromolecular API
5.2.2 Small Molecule API
5.3 Market Segment by Type
5.3.1 World Active Pharmaceutical Ingredients (API) CDMO Market Size by Type (2018-2023)
5.3.2 World Active Pharmaceutical Ingredients (API) CDMO Market Size by Type (2024-2029)
5.3.3 World Active Pharmaceutical Ingredients (API) CDMO Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Active Pharmaceutical Ingredients (API) CDMO Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Clinical
6.2.2 Commercial
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Active Pharmaceutical Ingredients (API) CDMO Market Size by Application (2018-2023)
6.3.2 World Active Pharmaceutical Ingredients (API) CDMO Market Size by Application (2024-2029)
6.3.3 World Active Pharmaceutical Ingredients (API) CDMO Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Recipharm
7.1.1 Recipharm Details
7.1.2 Recipharm Major Business
7.1.3 Recipharm Active Pharmaceutical Ingredients (API) CDMO Product and Services
7.1.4 Recipharm Active Pharmaceutical Ingredients (API) CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Recipharm Recent Developments/Updates
7.1.6 Recipharm Competitive Strengths & Weaknesses
7.2 Cambrex Corporation
7.2.1 Cambrex Corporation Details
7.2.2 Cambrex Corporation Major Business
7.2.3 Cambrex Corporation Active Pharmaceutical Ingredients (API) CDMO Product and Services
7.2.4 Cambrex Corporation Active Pharmaceutical Ingredients (API) CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Cambrex Corporation Recent Developments/Updates
7.2.6 Cambrex Corporation Competitive Strengths & Weaknesses
7.3 Patheon (Thermo Fisher Scientific)
7.3.1 Patheon (Thermo Fisher Scientific) Details
7.3.2 Patheon (Thermo Fisher Scientific) Major Business
7.3.3 Patheon (Thermo Fisher Scientific) Active Pharmaceutical Ingredients (API) CDMO Product and Services
7.3.4 Patheon (Thermo Fisher Scientific) Active Pharmaceutical Ingredients (API) CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Patheon (Thermo Fisher Scientific) Recent Developments/Updates
7.3.6 Patheon (Thermo Fisher Scientific) Competitive Strengths & Weaknesses
7.4 CordenPharma
7.4.1 CordenPharma Details
7.4.2 CordenPharma Major Business
7.4.3 CordenPharma Active Pharmaceutical Ingredients (API) CDMO Product and Services
7.4.4 CordenPharma Active Pharmaceutical Ingredients (API) CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 CordenPharma Recent Developments/Updates
7.4.6 CordenPharma Competitive Strengths & Weaknesses
7.5 Lonza
7.5.1 Lonza Details
7.5.2 Lonza Major Business
7.5.3 Lonza Active Pharmaceutical Ingredients (API) CDMO Product and Services
7.5.4 Lonza Active Pharmaceutical Ingredients (API) CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Lonza Recent Developments/Updates
7.5.6 Lonza Competitive Strengths & Weaknesses
7.6 Siegfried
7.6.1 Siegfried Details
7.6.2 Siegfried Major Business
7.6.3 Siegfried Active Pharmaceutical Ingredients (API) CDMO Product and Services
7.6.4 Siegfried Active Pharmaceutical Ingredients (API) CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Siegfried Recent Developments/Updates
7.6.6 Siegfried Competitive Strengths & Weaknesses
7.7 Catalent
7.7.1 Catalent Details
7.7.2 Catalent Major Business
7.7.3 Catalent Active Pharmaceutical Ingredients (API) CDMO Product and Services
7.7.4 Catalent Active Pharmaceutical Ingredients (API) CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Catalent Recent Developments/Updates
7.7.6 Catalent Competitive Strengths & Weaknesses
7.8 Boehringer Ingelheim
7.8.1 Boehringer Ingelheim Details
7.8.2 Boehringer Ingelheim Major Business
7.8.3 Boehringer Ingelheim Active Pharmaceutical Ingredients (API) CDMO Product and Services
7.8.4 Boehringer Ingelheim Active Pharmaceutical Ingredients (API) CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Boehringer Ingelheim Recent Developments/Updates
7.8.6 Boehringer Ingelheim Competitive Strengths & Weaknesses
7.9 Piramal Group
7.9.1 Piramal Group Details
7.9.2 Piramal Group Major Business
7.9.3 Piramal Group Active Pharmaceutical Ingredients (API) CDMO Product and Services
7.9.4 Piramal Group Active Pharmaceutical Ingredients (API) CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Piramal Group Recent Developments/Updates
7.9.6 Piramal Group Competitive Strengths & Weaknesses
7.10 AbbVie
7.10.1 AbbVie Details
7.10.2 AbbVie Major Business
7.10.3 AbbVie Active Pharmaceutical Ingredients (API) CDMO Product and Services
7.10.4 AbbVie Active Pharmaceutical Ingredients (API) CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 AbbVie Recent Developments/Updates
7.10.6 AbbVie Competitive Strengths & Weaknesses
7.11 SGS Quay Pharmaceuticals
7.11.1 SGS Quay Pharmaceuticals Details
7.11.2 SGS Quay Pharmaceuticals Major Business
7.11.3 SGS Quay Pharmaceuticals Active Pharmaceutical Ingredients (API) CDMO Product and Services
7.11.4 SGS Quay Pharmaceuticals Active Pharmaceutical Ingredients (API) CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 SGS Quay Pharmaceuticals Recent Developments/Updates
7.11.6 SGS Quay Pharmaceuticals Competitive Strengths & Weaknesses
7.12 Aenova Group
7.12.1 Aenova Group Details
7.12.2 Aenova Group Major Business
7.12.3 Aenova Group Active Pharmaceutical Ingredients (API) CDMO Product and Services
7.12.4 Aenova Group Active Pharmaceutical Ingredients (API) CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Aenova Group Recent Developments/Updates
7.12.6 Aenova Group Competitive Strengths & Weaknesses
7.13 Curia
7.13.1 Curia Details
7.13.2 Curia Major Business
7.13.3 Curia Active Pharmaceutical Ingredients (API) CDMO Product and Services
7.13.4 Curia Active Pharmaceutical Ingredients (API) CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Curia Recent Developments/Updates
7.13.6 Curia Competitive Strengths & Weaknesses
7.14 Sterling Pharma Solutions
7.14.1 Sterling Pharma Solutions Details
7.14.2 Sterling Pharma Solutions Major Business
7.14.3 Sterling Pharma Solutions Active Pharmaceutical Ingredients (API) CDMO Product and Services
7.14.4 Sterling Pharma Solutions Active Pharmaceutical Ingredients (API) CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Sterling Pharma Solutions Recent Developments/Updates
7.14.6 Sterling Pharma Solutions Competitive Strengths & Weaknesses
7.15 Eurofins CDMO
7.15.1 Eurofins CDMO Details
7.15.2 Eurofins CDMO Major Business
7.15.3 Eurofins CDMO Active Pharmaceutical Ingredients (API) CDMO Product and Services
7.15.4 Eurofins CDMO Active Pharmaceutical Ingredients (API) CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 Eurofins CDMO Recent Developments/Updates
7.15.6 Eurofins CDMO Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Active Pharmaceutical Ingredients (API) CDMO Industry Chain
8.2 Active Pharmaceutical Ingredients (API) CDMO Upstream Analysis
8.3 Active Pharmaceutical Ingredients (API) CDMO Midstream Analysis
8.4 Active Pharmaceutical Ingredients (API) CDMO Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Active Pharmaceutical Ingredients (API) CDMO Introduction
1.2 World Active Pharmaceutical Ingredients (API) CDMO Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Active Pharmaceutical Ingredients (API) CDMO Total Market by Region (by Headquarter Location)
1.3.1 World Active Pharmaceutical Ingredients (API) CDMO Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Active Pharmaceutical Ingredients (API) CDMO Market Size (2018-2029)
1.3.3 China Active Pharmaceutical Ingredients (API) CDMO Market Size (2018-2029)
1.3.4 Europe Active Pharmaceutical Ingredients (API) CDMO Market Size (2018-2029)
1.3.5 Japan Active Pharmaceutical Ingredients (API) CDMO Market Size (2018-2029)
1.3.6 South Korea Active Pharmaceutical Ingredients (API) CDMO Market Size (2018-2029)
1.3.7 ASEAN Active Pharmaceutical Ingredients (API) CDMO Market Size (2018-2029)
1.3.8 India Active Pharmaceutical Ingredients (API) CDMO Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Active Pharmaceutical Ingredients (API) CDMO Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Active Pharmaceutical Ingredients (API) CDMO Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Active Pharmaceutical Ingredients (API) CDMO Consumption Value (2018-2029)
2.2 World Active Pharmaceutical Ingredients (API) CDMO Consumption Value by Region
2.2.1 World Active Pharmaceutical Ingredients (API) CDMO Consumption Value by Region (2018-2023)
2.2.2 World Active Pharmaceutical Ingredients (API) CDMO Consumption Value Forecast by Region (2024-2029)
2.3 United States Active Pharmaceutical Ingredients (API) CDMO Consumption Value (2018-2029)
2.4 China Active Pharmaceutical Ingredients (API) CDMO Consumption Value (2018-2029)
2.5 Europe Active Pharmaceutical Ingredients (API) CDMO Consumption Value (2018-2029)
2.6 Japan Active Pharmaceutical Ingredients (API) CDMO Consumption Value (2018-2029)
2.7 South Korea Active Pharmaceutical Ingredients (API) CDMO Consumption Value (2018-2029)
2.8 ASEAN Active Pharmaceutical Ingredients (API) CDMO Consumption Value (2018-2029)
2.9 India Active Pharmaceutical Ingredients (API) CDMO Consumption Value (2018-2029)
3 WORLD ACTIVE PHARMACEUTICAL INGREDIENTS (API) CDMO COMPANIES COMPETITIVE ANALYSIS
3.1 World Active Pharmaceutical Ingredients (API) CDMO Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Active Pharmaceutical Ingredients (API) CDMO Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Active Pharmaceutical Ingredients (API) CDMO in 2022
3.2.3 Global Concentration Ratios (CR8) for Active Pharmaceutical Ingredients (API) CDMO in 2022
3.3 Active Pharmaceutical Ingredients (API) CDMO Company Evaluation Quadrant
3.4 Active Pharmaceutical Ingredients (API) CDMO Market: Overall Company Footprint Analysis
3.4.1 Active Pharmaceutical Ingredients (API) CDMO Market: Region Footprint
3.4.2 Active Pharmaceutical Ingredients (API) CDMO Market: Company Product Type Footprint
3.4.3 Active Pharmaceutical Ingredients (API) CDMO Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Active Pharmaceutical Ingredients (API) CDMO Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Active Pharmaceutical Ingredients (API) CDMO Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Active Pharmaceutical Ingredients (API) CDMO Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Active Pharmaceutical Ingredients (API) CDMO Consumption Value Comparison
4.2.1 United States VS China: Active Pharmaceutical Ingredients (API) CDMO Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Active Pharmaceutical Ingredients (API) CDMO Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Active Pharmaceutical Ingredients (API) CDMO Companies and Market Share, 2018-2023
4.3.1 United States Based Active Pharmaceutical Ingredients (API) CDMO Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Active Pharmaceutical Ingredients (API) CDMO Revenue, (2018-2023)
4.4 China Based Companies Active Pharmaceutical Ingredients (API) CDMO Revenue and Market Share, 2018-2023
4.4.1 China Based Active Pharmaceutical Ingredients (API) CDMO Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Active Pharmaceutical Ingredients (API) CDMO Revenue, (2018-2023)
4.5 Rest of World Based Active Pharmaceutical Ingredients (API) CDMO Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Active Pharmaceutical Ingredients (API) CDMO Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Active Pharmaceutical Ingredients (API) CDMO Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Active Pharmaceutical Ingredients (API) CDMO Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Macromolecular API
5.2.2 Small Molecule API
5.3 Market Segment by Type
5.3.1 World Active Pharmaceutical Ingredients (API) CDMO Market Size by Type (2018-2023)
5.3.2 World Active Pharmaceutical Ingredients (API) CDMO Market Size by Type (2024-2029)
5.3.3 World Active Pharmaceutical Ingredients (API) CDMO Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Active Pharmaceutical Ingredients (API) CDMO Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Clinical
6.2.2 Commercial
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Active Pharmaceutical Ingredients (API) CDMO Market Size by Application (2018-2023)
6.3.2 World Active Pharmaceutical Ingredients (API) CDMO Market Size by Application (2024-2029)
6.3.3 World Active Pharmaceutical Ingredients (API) CDMO Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Recipharm
7.1.1 Recipharm Details
7.1.2 Recipharm Major Business
7.1.3 Recipharm Active Pharmaceutical Ingredients (API) CDMO Product and Services
7.1.4 Recipharm Active Pharmaceutical Ingredients (API) CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Recipharm Recent Developments/Updates
7.1.6 Recipharm Competitive Strengths & Weaknesses
7.2 Cambrex Corporation
7.2.1 Cambrex Corporation Details
7.2.2 Cambrex Corporation Major Business
7.2.3 Cambrex Corporation Active Pharmaceutical Ingredients (API) CDMO Product and Services
7.2.4 Cambrex Corporation Active Pharmaceutical Ingredients (API) CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Cambrex Corporation Recent Developments/Updates
7.2.6 Cambrex Corporation Competitive Strengths & Weaknesses
7.3 Patheon (Thermo Fisher Scientific)
7.3.1 Patheon (Thermo Fisher Scientific) Details
7.3.2 Patheon (Thermo Fisher Scientific) Major Business
7.3.3 Patheon (Thermo Fisher Scientific) Active Pharmaceutical Ingredients (API) CDMO Product and Services
7.3.4 Patheon (Thermo Fisher Scientific) Active Pharmaceutical Ingredients (API) CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Patheon (Thermo Fisher Scientific) Recent Developments/Updates
7.3.6 Patheon (Thermo Fisher Scientific) Competitive Strengths & Weaknesses
7.4 CordenPharma
7.4.1 CordenPharma Details
7.4.2 CordenPharma Major Business
7.4.3 CordenPharma Active Pharmaceutical Ingredients (API) CDMO Product and Services
7.4.4 CordenPharma Active Pharmaceutical Ingredients (API) CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 CordenPharma Recent Developments/Updates
7.4.6 CordenPharma Competitive Strengths & Weaknesses
7.5 Lonza
7.5.1 Lonza Details
7.5.2 Lonza Major Business
7.5.3 Lonza Active Pharmaceutical Ingredients (API) CDMO Product and Services
7.5.4 Lonza Active Pharmaceutical Ingredients (API) CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Lonza Recent Developments/Updates
7.5.6 Lonza Competitive Strengths & Weaknesses
7.6 Siegfried
7.6.1 Siegfried Details
7.6.2 Siegfried Major Business
7.6.3 Siegfried Active Pharmaceutical Ingredients (API) CDMO Product and Services
7.6.4 Siegfried Active Pharmaceutical Ingredients (API) CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Siegfried Recent Developments/Updates
7.6.6 Siegfried Competitive Strengths & Weaknesses
7.7 Catalent
7.7.1 Catalent Details
7.7.2 Catalent Major Business
7.7.3 Catalent Active Pharmaceutical Ingredients (API) CDMO Product and Services
7.7.4 Catalent Active Pharmaceutical Ingredients (API) CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Catalent Recent Developments/Updates
7.7.6 Catalent Competitive Strengths & Weaknesses
7.8 Boehringer Ingelheim
7.8.1 Boehringer Ingelheim Details
7.8.2 Boehringer Ingelheim Major Business
7.8.3 Boehringer Ingelheim Active Pharmaceutical Ingredients (API) CDMO Product and Services
7.8.4 Boehringer Ingelheim Active Pharmaceutical Ingredients (API) CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Boehringer Ingelheim Recent Developments/Updates
7.8.6 Boehringer Ingelheim Competitive Strengths & Weaknesses
7.9 Piramal Group
7.9.1 Piramal Group Details
7.9.2 Piramal Group Major Business
7.9.3 Piramal Group Active Pharmaceutical Ingredients (API) CDMO Product and Services
7.9.4 Piramal Group Active Pharmaceutical Ingredients (API) CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Piramal Group Recent Developments/Updates
7.9.6 Piramal Group Competitive Strengths & Weaknesses
7.10 AbbVie
7.10.1 AbbVie Details
7.10.2 AbbVie Major Business
7.10.3 AbbVie Active Pharmaceutical Ingredients (API) CDMO Product and Services
7.10.4 AbbVie Active Pharmaceutical Ingredients (API) CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 AbbVie Recent Developments/Updates
7.10.6 AbbVie Competitive Strengths & Weaknesses
7.11 SGS Quay Pharmaceuticals
7.11.1 SGS Quay Pharmaceuticals Details
7.11.2 SGS Quay Pharmaceuticals Major Business
7.11.3 SGS Quay Pharmaceuticals Active Pharmaceutical Ingredients (API) CDMO Product and Services
7.11.4 SGS Quay Pharmaceuticals Active Pharmaceutical Ingredients (API) CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 SGS Quay Pharmaceuticals Recent Developments/Updates
7.11.6 SGS Quay Pharmaceuticals Competitive Strengths & Weaknesses
7.12 Aenova Group
7.12.1 Aenova Group Details
7.12.2 Aenova Group Major Business
7.12.3 Aenova Group Active Pharmaceutical Ingredients (API) CDMO Product and Services
7.12.4 Aenova Group Active Pharmaceutical Ingredients (API) CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Aenova Group Recent Developments/Updates
7.12.6 Aenova Group Competitive Strengths & Weaknesses
7.13 Curia
7.13.1 Curia Details
7.13.2 Curia Major Business
7.13.3 Curia Active Pharmaceutical Ingredients (API) CDMO Product and Services
7.13.4 Curia Active Pharmaceutical Ingredients (API) CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Curia Recent Developments/Updates
7.13.6 Curia Competitive Strengths & Weaknesses
7.14 Sterling Pharma Solutions
7.14.1 Sterling Pharma Solutions Details
7.14.2 Sterling Pharma Solutions Major Business
7.14.3 Sterling Pharma Solutions Active Pharmaceutical Ingredients (API) CDMO Product and Services
7.14.4 Sterling Pharma Solutions Active Pharmaceutical Ingredients (API) CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Sterling Pharma Solutions Recent Developments/Updates
7.14.6 Sterling Pharma Solutions Competitive Strengths & Weaknesses
7.15 Eurofins CDMO
7.15.1 Eurofins CDMO Details
7.15.2 Eurofins CDMO Major Business
7.15.3 Eurofins CDMO Active Pharmaceutical Ingredients (API) CDMO Product and Services
7.15.4 Eurofins CDMO Active Pharmaceutical Ingredients (API) CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 Eurofins CDMO Recent Developments/Updates
7.15.6 Eurofins CDMO Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Active Pharmaceutical Ingredients (API) CDMO Industry Chain
8.2 Active Pharmaceutical Ingredients (API) CDMO Upstream Analysis
8.3 Active Pharmaceutical Ingredients (API) CDMO Midstream Analysis
8.4 Active Pharmaceutical Ingredients (API) CDMO Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Active Pharmaceutical Ingredients (API) CDMO Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Active Pharmaceutical Ingredients (API) CDMO Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Active Pharmaceutical Ingredients (API) CDMO Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Active Pharmaceutical Ingredients (API) CDMO Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Active Pharmaceutical Ingredients (API) CDMO Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Active Pharmaceutical Ingredients (API) CDMO Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Active Pharmaceutical Ingredients (API) CDMO Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Active Pharmaceutical Ingredients (API) CDMO Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Active Pharmaceutical Ingredients (API) CDMO Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Active Pharmaceutical Ingredients (API) CDMO Players in 2022
Table 12. World Active Pharmaceutical Ingredients (API) CDMO Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Active Pharmaceutical Ingredients (API) CDMO Company Evaluation Quadrant
Table 14. Head Office of Key Active Pharmaceutical Ingredients (API) CDMO Player
Table 15. Active Pharmaceutical Ingredients (API) CDMO Market: Company Product Type Footprint
Table 16. Active Pharmaceutical Ingredients (API) CDMO Market: Company Product Application Footprint
Table 17. Active Pharmaceutical Ingredients (API) CDMO Mergers & Acquisitions Activity
Table 18. United States VS China Active Pharmaceutical Ingredients (API) CDMO Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Active Pharmaceutical Ingredients (API) CDMO Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Active Pharmaceutical Ingredients (API) CDMO Companies, Headquarters (States, Country)
Table 21. United States Based Companies Active Pharmaceutical Ingredients (API) CDMO Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Active Pharmaceutical Ingredients (API) CDMO Revenue Market Share (2018-2023)
Table 23. China Based Active Pharmaceutical Ingredients (API) CDMO Companies, Headquarters (Province, Country)
Table 24. China Based Companies Active Pharmaceutical Ingredients (API) CDMO Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Active Pharmaceutical Ingredients (API) CDMO Revenue Market Share (2018-2023)
Table 26. Rest of World Based Active Pharmaceutical Ingredients (API) CDMO Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Active Pharmaceutical Ingredients (API) CDMO Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Active Pharmaceutical Ingredients (API) CDMO Revenue Market Share (2018-2023)
Table 29. World Active Pharmaceutical Ingredients (API) CDMO Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Active Pharmaceutical Ingredients (API) CDMO Market Size by Type (2018-2023) & (USD Million)
Table 31. World Active Pharmaceutical Ingredients (API) CDMO Market Size by Type (2024-2029) & (USD Million)
Table 32. World Active Pharmaceutical Ingredients (API) CDMO Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Active Pharmaceutical Ingredients (API) CDMO Market Size by Application (2018-2023) & (USD Million)
Table 34. World Active Pharmaceutical Ingredients (API) CDMO Market Size by Application (2024-2029) & (USD Million)
Table 35. Recipharm Basic Information, Area Served and Competitors
Table 36. Recipharm Major Business
Table 37. Recipharm Active Pharmaceutical Ingredients (API) CDMO Product and Services
Table 38. Recipharm Active Pharmaceutical Ingredients (API) CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Recipharm Recent Developments/Updates
Table 40. Recipharm Competitive Strengths & Weaknesses
Table 41. Cambrex Corporation Basic Information, Area Served and Competitors
Table 42. Cambrex Corporation Major Business
Table 43. Cambrex Corporation Active Pharmaceutical Ingredients (API) CDMO Product and Services
Table 44. Cambrex Corporation Active Pharmaceutical Ingredients (API) CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Cambrex Corporation Recent Developments/Updates
Table 46. Cambrex Corporation Competitive Strengths & Weaknesses
Table 47. Patheon (Thermo Fisher Scientific) Basic Information, Area Served and Competitors
Table 48. Patheon (Thermo Fisher Scientific) Major Business
Table 49. Patheon (Thermo Fisher Scientific) Active Pharmaceutical Ingredients (API) CDMO Product and Services
Table 50. Patheon (Thermo Fisher Scientific) Active Pharmaceutical Ingredients (API) CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Patheon (Thermo Fisher Scientific) Recent Developments/Updates
Table 52. Patheon (Thermo Fisher Scientific) Competitive Strengths & Weaknesses
Table 53. CordenPharma Basic Information, Area Served and Competitors
Table 54. CordenPharma Major Business
Table 55. CordenPharma Active Pharmaceutical Ingredients (API) CDMO Product and Services
Table 56. CordenPharma Active Pharmaceutical Ingredients (API) CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. CordenPharma Recent Developments/Updates
Table 58. CordenPharma Competitive Strengths & Weaknesses
Table 59. Lonza Basic Information, Area Served and Competitors
Table 60. Lonza Major Business
Table 61. Lonza Active Pharmaceutical Ingredients (API) CDMO Product and Services
Table 62. Lonza Active Pharmaceutical Ingredients (API) CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Lonza Recent Developments/Updates
Table 64. Lonza Competitive Strengths & Weaknesses
Table 65. Siegfried Basic Information, Area Served and Competitors
Table 66. Siegfried Major Business
Table 67. Siegfried Active Pharmaceutical Ingredients (API) CDMO Product and Services
Table 68. Siegfried Active Pharmaceutical Ingredients (API) CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Siegfried Recent Developments/Updates
Table 70. Siegfried Competitive Strengths & Weaknesses
Table 71. Catalent Basic Information, Area Served and Competitors
Table 72. Catalent Major Business
Table 73. Catalent Active Pharmaceutical Ingredients (API) CDMO Product and Services
Table 74. Catalent Active Pharmaceutical Ingredients (API) CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Catalent Recent Developments/Updates
Table 76. Catalent Competitive Strengths & Weaknesses
Table 77. Boehringer Ingelheim Basic Information, Area Served and Competitors
Table 78. Boehringer Ingelheim Major Business
Table 79. Boehringer Ingelheim Active Pharmaceutical Ingredients (API) CDMO Product and Services
Table 80. Boehringer Ingelheim Active Pharmaceutical Ingredients (API) CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Boehringer Ingelheim Recent Developments/Updates
Table 82. Boehringer Ingelheim Competitive Strengths & Weaknesses
Table 83. Piramal Group Basic Information, Area Served and Competitors
Table 84. Piramal Group Major Business
Table 85. Piramal Group Active Pharmaceutical Ingredients (API) CDMO Product and Services
Table 86. Piramal Group Active Pharmaceutical Ingredients (API) CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Piramal Group Recent Developments/Updates
Table 88. Piramal Group Competitive Strengths & Weaknesses
Table 89. AbbVie Basic Information, Area Served and Competitors
Table 90. AbbVie Major Business
Table 91. AbbVie Active Pharmaceutical Ingredients (API) CDMO Product and Services
Table 92. AbbVie Active Pharmaceutical Ingredients (API) CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. AbbVie Recent Developments/Updates
Table 94. AbbVie Competitive Strengths & Weaknesses
Table 95. SGS Quay Pharmaceuticals Basic Information, Area Served and Competitors
Table 96. SGS Quay Pharmaceuticals Major Business
Table 97. SGS Quay Pharmaceuticals Active Pharmaceutical Ingredients (API) CDMO Product and Services
Table 98. SGS Quay Pharmaceuticals Active Pharmaceutical Ingredients (API) CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. SGS Quay Pharmaceuticals Recent Developments/Updates
Table 100. SGS Quay Pharmaceuticals Competitive Strengths & Weaknesses
Table 101. Aenova Group Basic Information, Area Served and Competitors
Table 102. Aenova Group Major Business
Table 103. Aenova Group Active Pharmaceutical Ingredients (API) CDMO Product and Services
Table 104. Aenova Group Active Pharmaceutical Ingredients (API) CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Aenova Group Recent Developments/Updates
Table 106. Aenova Group Competitive Strengths & Weaknesses
Table 107. Curia Basic Information, Area Served and Competitors
Table 108. Curia Major Business
Table 109. Curia Active Pharmaceutical Ingredients (API) CDMO Product and Services
Table 110. Curia Active Pharmaceutical Ingredients (API) CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Curia Recent Developments/Updates
Table 112. Curia Competitive Strengths & Weaknesses
Table 113. Sterling Pharma Solutions Basic Information, Area Served and Competitors
Table 114. Sterling Pharma Solutions Major Business
Table 115. Sterling Pharma Solutions Active Pharmaceutical Ingredients (API) CDMO Product and Services
Table 116. Sterling Pharma Solutions Active Pharmaceutical Ingredients (API) CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Sterling Pharma Solutions Recent Developments/Updates
Table 118. Eurofins CDMO Basic Information, Area Served and Competitors
Table 119. Eurofins CDMO Major Business
Table 120. Eurofins CDMO Active Pharmaceutical Ingredients (API) CDMO Product and Services
Table 121. Eurofins CDMO Active Pharmaceutical Ingredients (API) CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 122. Global Key Players of Active Pharmaceutical Ingredients (API) CDMO Upstream (Raw Materials)
Table 123. Active Pharmaceutical Ingredients (API) CDMO Typical Customers
Table 1. World Active Pharmaceutical Ingredients (API) CDMO Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Active Pharmaceutical Ingredients (API) CDMO Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Active Pharmaceutical Ingredients (API) CDMO Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Active Pharmaceutical Ingredients (API) CDMO Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Active Pharmaceutical Ingredients (API) CDMO Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Active Pharmaceutical Ingredients (API) CDMO Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Active Pharmaceutical Ingredients (API) CDMO Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Active Pharmaceutical Ingredients (API) CDMO Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Active Pharmaceutical Ingredients (API) CDMO Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Active Pharmaceutical Ingredients (API) CDMO Players in 2022
Table 12. World Active Pharmaceutical Ingredients (API) CDMO Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Active Pharmaceutical Ingredients (API) CDMO Company Evaluation Quadrant
Table 14. Head Office of Key Active Pharmaceutical Ingredients (API) CDMO Player
Table 15. Active Pharmaceutical Ingredients (API) CDMO Market: Company Product Type Footprint
Table 16. Active Pharmaceutical Ingredients (API) CDMO Market: Company Product Application Footprint
Table 17. Active Pharmaceutical Ingredients (API) CDMO Mergers & Acquisitions Activity
Table 18. United States VS China Active Pharmaceutical Ingredients (API) CDMO Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Active Pharmaceutical Ingredients (API) CDMO Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Active Pharmaceutical Ingredients (API) CDMO Companies, Headquarters (States, Country)
Table 21. United States Based Companies Active Pharmaceutical Ingredients (API) CDMO Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Active Pharmaceutical Ingredients (API) CDMO Revenue Market Share (2018-2023)
Table 23. China Based Active Pharmaceutical Ingredients (API) CDMO Companies, Headquarters (Province, Country)
Table 24. China Based Companies Active Pharmaceutical Ingredients (API) CDMO Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Active Pharmaceutical Ingredients (API) CDMO Revenue Market Share (2018-2023)
Table 26. Rest of World Based Active Pharmaceutical Ingredients (API) CDMO Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Active Pharmaceutical Ingredients (API) CDMO Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Active Pharmaceutical Ingredients (API) CDMO Revenue Market Share (2018-2023)
Table 29. World Active Pharmaceutical Ingredients (API) CDMO Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Active Pharmaceutical Ingredients (API) CDMO Market Size by Type (2018-2023) & (USD Million)
Table 31. World Active Pharmaceutical Ingredients (API) CDMO Market Size by Type (2024-2029) & (USD Million)
Table 32. World Active Pharmaceutical Ingredients (API) CDMO Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Active Pharmaceutical Ingredients (API) CDMO Market Size by Application (2018-2023) & (USD Million)
Table 34. World Active Pharmaceutical Ingredients (API) CDMO Market Size by Application (2024-2029) & (USD Million)
Table 35. Recipharm Basic Information, Area Served and Competitors
Table 36. Recipharm Major Business
Table 37. Recipharm Active Pharmaceutical Ingredients (API) CDMO Product and Services
Table 38. Recipharm Active Pharmaceutical Ingredients (API) CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Recipharm Recent Developments/Updates
Table 40. Recipharm Competitive Strengths & Weaknesses
Table 41. Cambrex Corporation Basic Information, Area Served and Competitors
Table 42. Cambrex Corporation Major Business
Table 43. Cambrex Corporation Active Pharmaceutical Ingredients (API) CDMO Product and Services
Table 44. Cambrex Corporation Active Pharmaceutical Ingredients (API) CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Cambrex Corporation Recent Developments/Updates
Table 46. Cambrex Corporation Competitive Strengths & Weaknesses
Table 47. Patheon (Thermo Fisher Scientific) Basic Information, Area Served and Competitors
Table 48. Patheon (Thermo Fisher Scientific) Major Business
Table 49. Patheon (Thermo Fisher Scientific) Active Pharmaceutical Ingredients (API) CDMO Product and Services
Table 50. Patheon (Thermo Fisher Scientific) Active Pharmaceutical Ingredients (API) CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Patheon (Thermo Fisher Scientific) Recent Developments/Updates
Table 52. Patheon (Thermo Fisher Scientific) Competitive Strengths & Weaknesses
Table 53. CordenPharma Basic Information, Area Served and Competitors
Table 54. CordenPharma Major Business
Table 55. CordenPharma Active Pharmaceutical Ingredients (API) CDMO Product and Services
Table 56. CordenPharma Active Pharmaceutical Ingredients (API) CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. CordenPharma Recent Developments/Updates
Table 58. CordenPharma Competitive Strengths & Weaknesses
Table 59. Lonza Basic Information, Area Served and Competitors
Table 60. Lonza Major Business
Table 61. Lonza Active Pharmaceutical Ingredients (API) CDMO Product and Services
Table 62. Lonza Active Pharmaceutical Ingredients (API) CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Lonza Recent Developments/Updates
Table 64. Lonza Competitive Strengths & Weaknesses
Table 65. Siegfried Basic Information, Area Served and Competitors
Table 66. Siegfried Major Business
Table 67. Siegfried Active Pharmaceutical Ingredients (API) CDMO Product and Services
Table 68. Siegfried Active Pharmaceutical Ingredients (API) CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Siegfried Recent Developments/Updates
Table 70. Siegfried Competitive Strengths & Weaknesses
Table 71. Catalent Basic Information, Area Served and Competitors
Table 72. Catalent Major Business
Table 73. Catalent Active Pharmaceutical Ingredients (API) CDMO Product and Services
Table 74. Catalent Active Pharmaceutical Ingredients (API) CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Catalent Recent Developments/Updates
Table 76. Catalent Competitive Strengths & Weaknesses
Table 77. Boehringer Ingelheim Basic Information, Area Served and Competitors
Table 78. Boehringer Ingelheim Major Business
Table 79. Boehringer Ingelheim Active Pharmaceutical Ingredients (API) CDMO Product and Services
Table 80. Boehringer Ingelheim Active Pharmaceutical Ingredients (API) CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Boehringer Ingelheim Recent Developments/Updates
Table 82. Boehringer Ingelheim Competitive Strengths & Weaknesses
Table 83. Piramal Group Basic Information, Area Served and Competitors
Table 84. Piramal Group Major Business
Table 85. Piramal Group Active Pharmaceutical Ingredients (API) CDMO Product and Services
Table 86. Piramal Group Active Pharmaceutical Ingredients (API) CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Piramal Group Recent Developments/Updates
Table 88. Piramal Group Competitive Strengths & Weaknesses
Table 89. AbbVie Basic Information, Area Served and Competitors
Table 90. AbbVie Major Business
Table 91. AbbVie Active Pharmaceutical Ingredients (API) CDMO Product and Services
Table 92. AbbVie Active Pharmaceutical Ingredients (API) CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. AbbVie Recent Developments/Updates
Table 94. AbbVie Competitive Strengths & Weaknesses
Table 95. SGS Quay Pharmaceuticals Basic Information, Area Served and Competitors
Table 96. SGS Quay Pharmaceuticals Major Business
Table 97. SGS Quay Pharmaceuticals Active Pharmaceutical Ingredients (API) CDMO Product and Services
Table 98. SGS Quay Pharmaceuticals Active Pharmaceutical Ingredients (API) CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. SGS Quay Pharmaceuticals Recent Developments/Updates
Table 100. SGS Quay Pharmaceuticals Competitive Strengths & Weaknesses
Table 101. Aenova Group Basic Information, Area Served and Competitors
Table 102. Aenova Group Major Business
Table 103. Aenova Group Active Pharmaceutical Ingredients (API) CDMO Product and Services
Table 104. Aenova Group Active Pharmaceutical Ingredients (API) CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Aenova Group Recent Developments/Updates
Table 106. Aenova Group Competitive Strengths & Weaknesses
Table 107. Curia Basic Information, Area Served and Competitors
Table 108. Curia Major Business
Table 109. Curia Active Pharmaceutical Ingredients (API) CDMO Product and Services
Table 110. Curia Active Pharmaceutical Ingredients (API) CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Curia Recent Developments/Updates
Table 112. Curia Competitive Strengths & Weaknesses
Table 113. Sterling Pharma Solutions Basic Information, Area Served and Competitors
Table 114. Sterling Pharma Solutions Major Business
Table 115. Sterling Pharma Solutions Active Pharmaceutical Ingredients (API) CDMO Product and Services
Table 116. Sterling Pharma Solutions Active Pharmaceutical Ingredients (API) CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Sterling Pharma Solutions Recent Developments/Updates
Table 118. Eurofins CDMO Basic Information, Area Served and Competitors
Table 119. Eurofins CDMO Major Business
Table 120. Eurofins CDMO Active Pharmaceutical Ingredients (API) CDMO Product and Services
Table 121. Eurofins CDMO Active Pharmaceutical Ingredients (API) CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 122. Global Key Players of Active Pharmaceutical Ingredients (API) CDMO Upstream (Raw Materials)
Table 123. Active Pharmaceutical Ingredients (API) CDMO Typical Customers
LIST OF FIGURES
Figure 1. Active Pharmaceutical Ingredients (API) CDMO Picture
Figure 2. World Active Pharmaceutical Ingredients (API) CDMO Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Active Pharmaceutical Ingredients (API) CDMO Total Market Size (2018-2029) & (USD Million)
Figure 4. World Active Pharmaceutical Ingredients (API) CDMO Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Active Pharmaceutical Ingredients (API) CDMO Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Active Pharmaceutical Ingredients (API) CDMO Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Active Pharmaceutical Ingredients (API) CDMO Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Active Pharmaceutical Ingredients (API) CDMO Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Active Pharmaceutical Ingredients (API) CDMO Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Active Pharmaceutical Ingredients (API) CDMO Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Active Pharmaceutical Ingredients (API) CDMO Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Active Pharmaceutical Ingredients (API) CDMO Revenue (2018-2029) & (USD Million)
Figure 13. Active Pharmaceutical Ingredients (API) CDMO Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Active Pharmaceutical Ingredients (API) CDMO Consumption Value (2018-2029) & (USD Million)
Figure 16. World Active Pharmaceutical Ingredients (API) CDMO Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Active Pharmaceutical Ingredients (API) CDMO Consumption Value (2018-2029) & (USD Million)
Figure 18. China Active Pharmaceutical Ingredients (API) CDMO Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Active Pharmaceutical Ingredients (API) CDMO Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Active Pharmaceutical Ingredients (API) CDMO Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Active Pharmaceutical Ingredients (API) CDMO Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Active Pharmaceutical Ingredients (API) CDMO Consumption Value (2018-2029) & (USD Million)
Figure 23. India Active Pharmaceutical Ingredients (API) CDMO Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Active Pharmaceutical Ingredients (API) CDMO by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Active Pharmaceutical Ingredients (API) CDMO Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Active Pharmaceutical Ingredients (API) CDMO Markets in 2022
Figure 27. United States VS China: Active Pharmaceutical Ingredients (API) CDMO Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Active Pharmaceutical Ingredients (API) CDMO Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Active Pharmaceutical Ingredients (API) CDMO Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Active Pharmaceutical Ingredients (API) CDMO Market Size Market Share by Type in 2022
Figure 31. Macromolecular API
Figure 32. Small Molecule API
Figure 33. World Active Pharmaceutical Ingredients (API) CDMO Market Size Market Share by Type (2018-2029)
Figure 34. World Active Pharmaceutical Ingredients (API) CDMO Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World Active Pharmaceutical Ingredients (API) CDMO Market Size Market Share by Application in 2022
Figure 36. Clinical
Figure 37. Commercial
Figure 38. Others
Figure 39. Active Pharmaceutical Ingredients (API) CDMO Industrial Chain
Figure 40. Methodology
Figure 41. Research Process and Data Source
Figure 1. Active Pharmaceutical Ingredients (API) CDMO Picture
Figure 2. World Active Pharmaceutical Ingredients (API) CDMO Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Active Pharmaceutical Ingredients (API) CDMO Total Market Size (2018-2029) & (USD Million)
Figure 4. World Active Pharmaceutical Ingredients (API) CDMO Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Active Pharmaceutical Ingredients (API) CDMO Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Active Pharmaceutical Ingredients (API) CDMO Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Active Pharmaceutical Ingredients (API) CDMO Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Active Pharmaceutical Ingredients (API) CDMO Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Active Pharmaceutical Ingredients (API) CDMO Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Active Pharmaceutical Ingredients (API) CDMO Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Active Pharmaceutical Ingredients (API) CDMO Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Active Pharmaceutical Ingredients (API) CDMO Revenue (2018-2029) & (USD Million)
Figure 13. Active Pharmaceutical Ingredients (API) CDMO Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Active Pharmaceutical Ingredients (API) CDMO Consumption Value (2018-2029) & (USD Million)
Figure 16. World Active Pharmaceutical Ingredients (API) CDMO Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Active Pharmaceutical Ingredients (API) CDMO Consumption Value (2018-2029) & (USD Million)
Figure 18. China Active Pharmaceutical Ingredients (API) CDMO Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Active Pharmaceutical Ingredients (API) CDMO Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Active Pharmaceutical Ingredients (API) CDMO Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Active Pharmaceutical Ingredients (API) CDMO Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Active Pharmaceutical Ingredients (API) CDMO Consumption Value (2018-2029) & (USD Million)
Figure 23. India Active Pharmaceutical Ingredients (API) CDMO Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Active Pharmaceutical Ingredients (API) CDMO by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Active Pharmaceutical Ingredients (API) CDMO Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Active Pharmaceutical Ingredients (API) CDMO Markets in 2022
Figure 27. United States VS China: Active Pharmaceutical Ingredients (API) CDMO Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Active Pharmaceutical Ingredients (API) CDMO Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Active Pharmaceutical Ingredients (API) CDMO Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Active Pharmaceutical Ingredients (API) CDMO Market Size Market Share by Type in 2022
Figure 31. Macromolecular API
Figure 32. Small Molecule API
Figure 33. World Active Pharmaceutical Ingredients (API) CDMO Market Size Market Share by Type (2018-2029)
Figure 34. World Active Pharmaceutical Ingredients (API) CDMO Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World Active Pharmaceutical Ingredients (API) CDMO Market Size Market Share by Application in 2022
Figure 36. Clinical
Figure 37. Commercial
Figure 38. Others
Figure 39. Active Pharmaceutical Ingredients (API) CDMO Industrial Chain
Figure 40. Methodology
Figure 41. Research Process and Data Source
